tirzepatide vs semaglutide reviews
Semaglutide Vs Tirzepatide Which Saves More Lives?
The SURPASS-3 trial showed tirzepatide cut body weight by 15% over 72 weeks, a result linked to lower mortality risk in obese patients. In my practice, that degree of loss often moves patients from severe to moderate risk categories, making tirzepatide a strong contender for saving more lives. Medical Disclaimer: